Page last updated: 2024-10-29

ketamine and Facial Neoplasms

ketamine has been researched along with Facial Neoplasms in 2 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Facial Neoplasms: New abnormal growth of tissue in the FACE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kurt, E1
Külahçi, Y1
Zor, F1
Celiköz, B1
Baronia, AK1
Pandey, CK1
Kaushik, S1

Other Studies

2 other studies available for ketamine and Facial Neoplasms

ArticleYear
Anesthesia during intralesional bare fiber laser treatment of a giant hemangioma of head and neck region of an infant using the laryngeal mask airway.
    Paediatric anaesthesia, 2004, Volume: 14, Issue:12

    Topics: Airway Obstruction; Analgesics; Anesthesia, General; Anesthetics, Inhalation; Facial Neoplasms; Hema

2004
Diffuse oral facial cavernous hemangioma causing severe airway obstruction after intramuscular ketamine.
    Anesthesiology, 1993, Volume: 79, Issue:6

    Topics: Airway Obstruction; Child, Preschool; Facial Neoplasms; Hemangioma, Cavernous; Humans; Injections, I

1993